Cardinal Remains Neutral
We maintain our rating on Cardinal Health (NYSE:CAH) at Neutral. Earnings for the third quarter beat the Zacks Consensus Estimate by $0.06. Earnings from continuing operations (as reported) were up about 33% year over year to $332.5 million (or $0.95 a share). Revenues in the third quarter increased 3% year over year to $26.9 billion, [...]
We maintain our rating on Cardinal Health (NYSE:CAH) at Neutral. Earnings for the third quarter beat the Zacks Consensus Estimate by $0.06. Earnings from continuing operations (as reported) were up about 33% year over year to $332.5 million (or $0.95 a share).
Revenues in the third quarter increased 3% year over year to $26.9 billion, beating the Zacks Consensus Estimate of $26.6 billion. The Pharmaceutical segment recorded revenues of $24.5 billion in the quarter, a 3% year-over-year increase, … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards